<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>IIH Explained - Understanding Idiopathic Intracranial Hypertension</title>
    <meta name="description" content="Comprehensive resource for understanding Idiopathic Intracranial Hypertension (IIH) - symptoms, diagnosis, treatments, and research-backed information.">
    <link rel="stylesheet" href="styles.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
</head>
<body>
    <header class="header">
        <nav class="nav">
            <div class="nav-container">
                <div class="nav-logo">
                    <h1>IIH Explained</h1>
                    <p>Understanding Idiopathic Intracranial Hypertension</p>
                </div>
                <ul class="nav-menu">
                    <li><a href="#what-is-iih">What is IIH?</a></li>
                    <li><a href="#symptoms">Symptoms</a></li>
                    <li><a href="#diagnosis">Diagnosis</a></li>
                    <li><a href="#treatments">Treatments</a></li>
                    <li><a href="#research">Research</a></li>
                    <li><a href="#resources">Resources</a></li>
                </ul>
                <button class="nav-toggle" aria-label="Toggle navigation">
                    <span></span>
                    <span></span>
                    <span></span>
                </button>
            </div>
        </nav>
    </header>

    <main class="main">
        <section class="hero">
            <div class="container">
                <h2>Your comprehensive guide to understanding IIH</h2>
                <p>Evidence-based information about Idiopathic Intracranial Hypertension, backed by current research and medical expertise.</p>
                <div class="hero-actions">
                    <a href="#what-is-iih" class="btn btn-primary">Learn About IIH</a>
                    <a href="#symptoms" class="btn btn-secondary">Recognize Symptoms</a>
                </div>
            </div>
        </section>

        <section id="what-is-iih" class="section">
            <div class="container">
                <h2>What is Idiopathic Intracranial Hypertension?</h2>
                <div class="content-grid">
                    <div class="content-text">
                        <p>Idiopathic Intracranial Hypertension (IIH), formerly known as pseudotumor cerebri, is a neurological condition characterized by increased pressure within the skull (intracranial pressure) without an identifiable cause.</p>
                        
                        <h3>Key Features:</h3>
                        <ul>
                            <li><strong>Idiopathic:</strong> No identifiable underlying cause</li>
                            <li><strong>Intracranial:</strong> Occurs within the skull</li>
                            <li><strong>Hypertension:</strong> Elevated pressure</li>
                        </ul>

                        <h3>Who Does IIH Affect?</h3>
                        <p>IIH primarily affects women of childbearing age, particularly those who are overweight. However, it can occur in anyone, including children and men.</p>
                        
                        <div class="statistics">
                            <div class="stat">
                                <h4>90%</h4>
                                <p>of cases occur in women</p>
                            </div>
                            <div class="stat">
                                <h4>20-40</h4>
                                <p>typical age range</p>
                            </div>
                            <div class="stat">
                                <h4>1-2 per 100,000</h4>
                                <p>annual incidence rate</p>
                            </div>
                        </div>
                    </div>
                    <div class="content-visual">
                        <div class="info-box">
                            <h4>Important Note</h4>
                            <p>IIH can cause permanent vision loss if left untreated. Early diagnosis and treatment are crucial for preserving vision and managing symptoms.</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section id="symptoms" class="section section-gray">
            <div class="container">
                <h2>Symptoms of IIH</h2>
                <p class="section-intro">IIH symptoms are primarily related to increased intracranial pressure and can significantly impact quality of life.</p>
                
                <div class="symptoms-grid">
                    <div class="symptom-category">
                        <h3>Primary Symptoms</h3>
                        <ul class="symptom-list">
                            <li>
                                <strong>Headaches</strong>
                                <p>Often severe, daily headaches that may worsen with coughing, sneezing, or straining</p>
                            </li>
                            <li>
                                <strong>Visual Disturbances</strong>
                                <p>Blurred vision, double vision, or temporary vision loss</p>
                            </li>
                            <li>
                                <strong>Papilledema</strong>
                                <p>Swelling of the optic nerve visible during eye examination</p>
                            </li>
                            <li>
                                <strong>Pulsatile Tinnitus</strong>
                                <p>Hearing a rhythmic sound that matches your heartbeat</p>
                            </li>
                        </ul>
                    </div>
                    
                    <div class="symptom-category">
                        <h3>Secondary Symptoms</h3>
                        <ul class="symptom-list">
                            <li>
                                <strong>Nausea and Vomiting</strong>
                                <p>Often accompanying severe headaches</p>
                            </li>
                            <li>
                                <strong>Neck and Shoulder Pain</strong>
                                <p>Tension and stiffness in neck muscles</p>
                            </li>
                            <li>
                                <strong>Cognitive Issues</strong>
                                <p>Memory problems, difficulty concentrating</p>
                            </li>
                            <li>
                                <strong>Fatigue</strong>
                                <p>Persistent tiredness and low energy</p>
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="warning-box">
                    <h4>⚠️ Seek Immediate Medical Attention If:</h4>
                    <ul>
                        <li>Sudden severe headache unlike any previous headache</li>
                        <li>Sudden vision changes or vision loss</li>
                        <li>Persistent vomiting with headache</li>
                        <li>Changes in consciousness or confusion</li>
                    </ul>
                </div>
            </div>
        </section>

        <section id="diagnosis" class="section">
            <div class="container">
                <h2>Diagnosis of IIH</h2>
                <p class="section-intro">Diagnosing IIH requires a comprehensive evaluation to rule out other causes of increased intracranial pressure.</p>
                
                <div class="diagnosis-process">
                    <h3>Modified Dandy Criteria</h3>
                    <p>The diagnosis of IIH is based on the Modified Dandy Criteria:</p>
                    
                    <ol class="criteria-list">
                        <li>
                            <strong>Papilledema</strong>
                            <p>Swelling of the optic disc visible on fundoscopy</p>
                        </li>
                        <li>
                            <strong>Normal neurological examination</strong>
                            <p>Except for cranial nerve abnormalities</p>
                        </li>
                        <li>
                            <strong>Normal brain imaging</strong>
                            <p>CT or MRI shows no mass lesion, hydrocephalus, or structural abnormality</p>
                        </li>
                        <li>
                            <strong>Normal CSF composition</strong>
                            <p>Cerebrospinal fluid analysis shows normal cell count and chemistry</p>
                        </li>
                        <li>
                            <strong>Elevated opening pressure</strong>
                            <p>Lumbar puncture reveals opening pressure ≥250 mmH₂O (≥200 mmH₂O in children)</p>
                        </li>
                    </ol>
                </div>

                <div class="diagnostic-tests">
                    <h3>Diagnostic Tests</h3>
                    <div class="tests-grid">
                        <div class="test">
                            <h4>Fundoscopy</h4>
                            <p>Eye examination to detect papilledema and monitor optic nerve swelling</p>
                        </div>
                        <div class="test">
                            <h4>Visual Field Testing</h4>
                            <p>Perimetry to assess peripheral vision and detect blind spots</p>
                        </div>
                        <div class="test">
                            <h4>Advanced Brain Imaging</h4>
                            <p>MRI with MR venography to rule out tumors, detect venous sinus stenosis, and identify indirect signs of raised pressure (empty sella, slit ventricles)</p>
                        </div>
                        <div class="test">
                            <h4>Lumbar Puncture</h4>
                            <p>Spinal tap to measure cerebrospinal fluid pressure and composition</p>
                        </div>
                        <div class="test">
                            <h4>OCT Scan</h4>
                            <p>Optical coherence tomography provides quantitative measurement of optic nerve head edema and retinal nerve fiber layer thickness. Essential for confirming papilledema and monitoring treatment response</p>
                        </div>
                        <div class="test">
                            <h4>Blood Tests</h4>
                            <p>To rule out secondary causes of intracranial hypertension</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section id="treatments" class="section section-gray">
            <div class="container">
                <h2>Treatment Options for IIH</h2>
                <p class="section-intro">Treatment aims to reduce intracranial pressure, preserve vision, and manage symptoms. Approach varies based on severity and individual patient factors.</p>
                
                <div class="treatment-categories">
                    <div class="treatment-category">
                        <h3>First-Line Treatments</h3>
                        <div class="treatment-grid">
                            <div class="treatment">
                                <h4>Weight Loss</h4>
                                <p>5-10% weight reduction can significantly improve symptoms. Sustained weight loss can lead to disease remission in many patients</p>
                                <div class="evidence">Evidence Level: Strong</div>
                            </div>
                            <div class="treatment">
                                <h4>Acetazolamide (Diamox)</h4>
                                <p>Carbonic anhydrase inhibitor that reduces CSF production</p>
                                <div class="evidence">Evidence Level: Strong</div>
                            </div>
                            <div class="treatment">
                                <h4>Bariatric Surgery</h4>
                                <p>For patients with severe obesity, bariatric surgery shows substantial symptom improvement and medication reduction</p>
                                <div class="evidence">Evidence Level: Strong</div>
                            </div>
                        </div>
                    </div>

                    <div class="treatment-category">
                        <h3>Emerging Medical Therapies</h3>
                        <div class="treatment-grid">
                            <div class="treatment">
                                <h4>GLP-1 Receptor Agonists</h4>
                                <p>Exenatide shows direct ICP reduction and significant headache improvement. Phase III trials ongoing for first licensed IIH medication</p>
                                <div class="evidence">Evidence Level: Phase II Complete</div>
                            </div>
                            <div class="treatment">
                                <h4>Topiramate (Topamax)</h4>
                                <p>Multi-benefit therapy: reduces ICP, promotes weight loss, and controls headaches. Increasingly used as initial therapy</p>
                                <div class="evidence">Evidence Level: Moderate</div>
                            </div>
                            <div class="treatment">
                                <h4>Furosemide (Lasix)</h4>
                                <p>Loop diuretic used when acetazolamide is not tolerated</p>
                                <div class="evidence">Evidence Level: Limited</div>
                            </div>
                        </div>
                    </div>

                    <div class="treatment-category">
                        <h3>Surgical Interventions</h3>
                        <div class="treatment-grid">
                            <div class="treatment">
                                <h4>Optic Nerve Sheath Fenestration</h4>
                                <p>Creates opening in optic nerve sheath to relieve pressure on the nerve</p>
                                <div class="indication">For: Severe visual field defects</div>
                            </div>
                            <div class="treatment">
                                <h4>CSF Shunting</h4>
                                <p>Lumboperitoneal or ventriculoperitoneal shunt to divert excess CSF</p>
                                <div class="indication">For: Refractory headaches</div>
                            </div>
                            <div class="treatment">
                                <h4>Venous Sinus Stenting</h4>
                                <p>Minimally invasive stent placement in stenotic venous sinuses. 94% improvement in papilledema, 80% headache improvement, superior safety profile to shunts</p>
                                <div class="indication">For: Venous pressure gradient >8-10 mmHg</div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="treatment-algorithm">
                    <h3>Treatment Algorithm</h3>
                    <div class="algorithm-flow">
                        <div class="step">
                            <h4>Step 1: Lifestyle Modifications</h4>
                            <p>Weight loss, dietary changes, regular exercise</p>
                        </div>
                        <div class="step">
                            <h4>Step 2: Medical Therapy</h4>
                            <p>Acetazolamide ± weight loss program</p>
                        </div>
                        <div class="step">
                            <h4>Step 3: Alternative Medications</h4>
                            <p>Topiramate or furosemide if acetazolamide not tolerated</p>
                        </div>
                        <div class="step">
                            <h4>Step 4: Surgical Intervention</h4>
                            <p>Consider surgery for refractory cases or vision-threatening disease</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section id="research" class="section">
            <div class="container">
                <h2>Current Research & Evidence</h2>
                <p class="section-intro">Stay updated with the latest research findings and clinical studies on IIH.</p>
                
                <div class="research-categories">
                    <div class="research-category">
                        <h3>Key Clinical Trials</h3>
                        <div class="research-papers">
                            <div class="paper">
                                <h4>IIHTT (IIH Treatment Trial)</h4>
                                <p class="authors">NORDIC Idiopathic Intracranial Hypertension Study Group</p>
                                <p class="journal">NEJM, 2014</p>
                                <p class="summary">Landmark randomized controlled trial demonstrating efficacy of acetazolamide plus weight loss in IIH treatment.</p>
                                <div class="paper-tags">
                                    <span class="tag">RCT</span>
                                    <span class="tag">Level 1 Evidence</span>
                                </div>
                            </div>
                            
                            <div class="paper">
                                <h4>IIH Pressure Trial - Exenatide for IIH</h4>
                                <p class="authors">Birmingham IIH Research Group</p>
                                <p class="journal">Brain, 2023</p>
                                <p class="summary">Phase II trial demonstrating that GLP-1 agonist exenatide significantly reduces intracranial pressure and headache frequency in IIH patients.</p>
                                <div class="paper-tags">
                                    <span class="tag">Phase II RCT</span>
                                    <span class="tag">Breakthrough Study</span>
                                </div>
                            </div>
                            
                            <div class="paper">
                                <h4>Bariatric Surgery Outcomes in IIH</h4>
                                <p class="authors">Cleveland Clinic Study Group</p>
                                <p class="journal">Neurology, 2025</p>
                                <p class="summary">97-patient study showing substantial symptom improvement and medication reduction following bariatric surgery, with durable long-term remission.</p>
                                <div class="paper-tags">
                                    <span class="tag">Observational Study</span>
                                    <span class="tag">Long-term Follow-up</span>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="research-category">
                        <h3>Breakthrough Research & Future Directions</h3>
                        <div class="emerging-treatments">
                            <div class="treatment-research">
                                <h4>GLP-1 Agonist Trials (IIH Advance & Evolve)</h4>
                                <p>Phase III trials of weekly exenatide (Presendin) in adolescents and adults underway. Could lead to first FDA-approved medication for IIH.</p>
                                <div class="status">Status: Phase III Active</div>
                            </div>
                            
                            <div class="treatment-research">
                                <h4>AI-Assisted Diagnosis</h4>
                                <p>Deep learning algorithms trained on OCT images to automatically detect papilledema and early optic nerve changes for screening in primary care.</p>
                                <div class="status">Status: Development Phase</div>
                            </div>
                            
                            <div class="treatment-research">
                                <h4>Non-Invasive ICP Monitoring</h4>
                                <p>4D flow MRI, ultrasound ONSD measurement, and novel sensors under development to estimate intracranial pressure without lumbar puncture.</p>
                                <div class="status">Status: Pilot Studies</div>
                            </div>
                            
                            <div class="treatment-research">
                                <h4>Hormonal & Metabolic Pathways</h4>
                                <p>Research into androgen excess profiles and 11β-HSD1 inhibitors targeting the metabolic dysfunction underlying IIH.</p>
                                <div class="status">Status: Early Clinical Trials</div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="research-updates">
                    <h3>2023-2024 Research Highlights</h3>
                    <div class="updates-list">
                        <div class="update">
                            <div class="date">2024</div>
                            <div class="content">
                                <h4>Venous Stenting Preference Shift</h4>
                                <p>VSS procedures increased 80% annually (2016-2020) while shunt surgeries declined. Meta-analysis shows 94% papilledema improvement with superior safety profile.</p>
                            </div>
                        </div>
                        <div class="update">
                            <div class="date">2023</div>
                            <div class="content">
                                <h4>First Direct ICP-Lowering Drug</h4>
                                <p>IIH Pressure Trial proves exenatide directly reduces brain pressure within hours, with 7-8 fewer headache days per month vs placebo.</p>
                            </div>
                        </div>
                        <div class="update">
                            <div class="date">2023</div>
                            <div class="content">
                                <h4>Pathophysiology Advances</h4>
                                <p>Recognition of unique androgen excess profile and metabolic dysfunction patterns in IIH patients, moving beyond "idiopathic" classification.</p>
                            </div>
                        </div>
                        <div class="update">
                            <div class="date">2024</div>
                            <div class="content">
                                <h4>Enhanced Diagnostic Tools</h4>
                                <p>OCT now standard for quantitative papilledema assessment. Advanced MR venography recommended even without papilledema when symptoms suggest IIH.</p>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section id="resources" class="section section-gray">
            <div class="container">
                <h2>Resources & Support</h2>
                
                <div class="resources-grid">
                    <div class="resource-category">
                        <h3>Patient Organizations</h3>
                        <ul class="resource-list">
                            <li>
                                <a href="https://iihresearch.org" target="_blank" rel="noopener">
                                    <strong>IIH Research Foundation</strong>
                                    <p>Patient advocacy and research funding organization</p>
                                </a>
                            </li>
                            <li>
                                <a href="https://www.ninds.nih.gov" target="_blank" rel="noopener">
                                    <strong>NINDS</strong>
                                    <p>National Institute of Neurological Disorders and Stroke</p>
                                </a>
                            </li>
                        </ul>
                    </div>
                    
                    <div class="resource-category">
                        <h3>Medical Guidelines</h3>
                        <ul class="resource-list">
                            <li>
                                <strong>American Academy of Neurology</strong>
                                <p>Practice guidelines for IIH diagnosis and management</p>
                            </li>
                            <li>
                                <strong>European Society of Neurology</strong>
                                <p>European guidelines for IIH treatment</p>
                            </li>
                        </ul>
                    </div>
                    
                    <div class="resource-category">
                        <h3>Educational Materials</h3>
                        <ul class="resource-list">
                            <li>
                                <strong>Patient Information Sheets</strong>
                                <p>Downloadable guides for patients and families</p>
                            </li>
                            <li>
                                <strong>Symptom Tracking Tools</strong>
                                <p>Templates for monitoring symptoms and treatment response</p>
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="disclaimer">
                    <h3>Medical Disclaimer</h3>
                    <p>This website provides educational information about IIH and should not replace professional medical advice. Always consult with qualified healthcare providers for diagnosis and treatment decisions. The information presented is based on current medical literature and may not reflect the most recent research findings.</p>
                </div>
            </div>
        </section>
    </main>

    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-section">
                    <h4>IIH Explained</h4>
                    <p>Providing evidence-based information about Idiopathic Intracranial Hypertension to patients, families, and healthcare providers.</p>
                </div>
                <div class="footer-section">
                    <h4>Quick Links</h4>
                    <ul>
                        <li><a href="#what-is-iih">What is IIH?</a></li>
                        <li><a href="#symptoms">Symptoms</a></li>
                        <li><a href="#diagnosis">Diagnosis</a></li>
                        <li><a href="#treatments">Treatments</a></li>
                    </ul>
                </div>
                <div class="footer-section">
                    <h4>Resources</h4>
                    <ul>
                        <li><a href="#research">Current Research</a></li>
                        <li><a href="#resources">Support Organizations</a></li>
                        <li><a href="#resources">Guidelines</a></li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2024 IIH Explained. Educational content for informational purposes only.</p>
                <p>Last updated: <span id="last-updated"></span></p>
            </div>
        </div>
    </footer>

    <script src="script.js"></script>
</body>
</html>